Clinical Trials Directory

Trials / Unknown

UnknownNCT04716842

Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.

Status
Unknown
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Inonu University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Evaluation of plasma angiotensin II and angiotensin II receptor levels in patients with sepsis and septic shock: a prospective observational study.

Detailed description

There is an increasing number of experimental publications investigated effects of angiotensin II and receptors on the pathogenesis and treatment of sepsis and septic shock. However, its level in humans and its relationship with the severity of the disease has not been investigated. If angiotensin II plays a role in the diagnosis and prognosis of septic shock by evaluating this relationship in our study, it may be a biomarker to be used in future diagnosis, prediction of prognosis and treatment. This will enable early recognition and treatment of this disease, which causes high mortality and cost in intensive care units, thus increasing the survival rate and reducing the cost.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2021-04-01
Completion
2021-04-01
First posted
2021-01-20
Last updated
2021-01-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04716842. Inclusion in this directory is not an endorsement.

Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prosp (NCT04716842) · Clinical Trials Directory